IgA nephropathy

E Stamellou, C Seikrit, SCW Tang, P Boor… - Nature Reviews …, 2023 - nature.com
IgA nephropathy (IgAN), the most prevalent primary glomerulonephritis worldwide, carries a
considerable lifetime risk of kidney failure. Clinical manifestations of IgAN vary from …

Treatment of IgA nephropathy: a rapidly evolving field

K El Karoui, FC Fervenza… - Journal of the American …, 2024 - journals.lww.com
The pivotal event in the pathophysiology of IgA nephropathy is the binding of circulating IgA-
containing immune complexes to mesangial cells, with secondary glomerular and …

[HTML][HTML] The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

M Vivarelli, J Barratt, LH Beck Jr, F Fakhouri, DP Gale… - Kidney international, 2024 - Elsevier
Uncontrolled complement activation can cause or contribute to glomerular injury in multiple
kidney diseases. Although complement activation plays a causal role in atypical hemolytic …

The treatment of primary IgA nephropathy: change, change, change

DJ Caster, RA Lafayette - American Journal of Kidney Diseases, 2024 - Elsevier
IgA nephropathy (IgAN) is the most common glomerular disease in the world. However, the
approach to treatment remains controversial. There has been an explosion of clinical trials …

IgA nephropathy in adults—treatment standard

PJ Gleeson, MM O'Shaughnessy… - Nephrology Dialysis …, 2023 - academic.oup.com
Immunoglobulin A nephropathy (IgAN) is the most common primary form of glomerular
disease worldwide and carries a high lifetime risk of kidney failure. The underlying …

IgA nephropathy: current understanding and perspectives on pathogenesis and targeted treatment

Y Du, T Cheng, C Liu, T Zhu, C Guo, S Li, X Rao, J Li - Diagnostics, 2023 - mdpi.com
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide, with varied clinical and histopathological features between individuals …

KDOQI US commentary on the 2021 KDIGO clinical practice guideline for the management of glomerular diseases

LH Beck Jr, I Ayoub, D Caster, MJ Choi, J Cobb… - American Journal of …, 2023 - Elsevier
The KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
represents the first update to this set of recommendations since the initial set of KDIGO …

[HTML][HTML] Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsy

SJ Barbour, R Coppo, L Er, ML Russo, ZH Liu, J Ding… - Kidney International, 2024 - Elsevier
The pediatric International IgA Nephropathy (IgAN) Prediction Tool comprises two models
with and without ethnicity and is the first method to predict the risk of a 30% decline in …

Systematic review of the oxford classification of IgA nephropathy: reproducibility and prognostic value

AJ Howie, AD Lalayiannis - Kidney360, 2023 - journals.lww.com
Background The Oxford classification of IgA nephropathy defined five prognostic features
scored subjectively in renal biopsies: mesangial cellularity (M), endocapillary …

Novel agents for treating IgA nephropathy

U Kunter, C Seikrit, J Floege - Current Opinion in Nephrology and …, 2023 - journals.lww.com
Current Opinion in Nephrology and Hypertension Log in or Register Subscribe to journalSubscribe
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …